Page last updated: 2024-09-03

tyrosyl-glycyl-glycine and HIV Coinfection

tyrosyl-glycyl-glycine has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gottlieb, AA; Gottlieb, MS; Kern, CH; Sizemore, RC	1

Trials

1 trial(s) available for tyrosyl-glycyl-glycine and HIV Coinfection

Article	Year
Rationale and clinical results of using leucocyte-derived immunosupportive therapies in HIV disease. Biotherapy (Dordrecht, Netherlands), 1996, Volume: 9, Issue:1-3 Topics: Adjuvants, Immunologic; Antiviral Agents; Binding Sites; CD4-Positive T-Lymphocytes; Double-Blind Method; HIV Infections; Humans; Hypersensitivity, Delayed; Immunologic Factors; Leukocytes, Mononuclear; Lymphokines; Placebos; Tetanus Toxoid	1996

Article

Year

Rationale and clinical results of using leucocyte-derived immunosupportive therapies in HIV disease.

Biotherapy (Dordrecht, Netherlands), 1996, Volume: 9, Issue:1-3

Topics: Adjuvants, Immunologic; Antiviral Agents; Binding Sites; CD4-Positive T-Lymphocytes; Double-Blind Method; HIV Infections; Humans; Hypersensitivity, Delayed; Immunologic Factors; Leukocytes, Mononuclear; Lymphokines; Placebos; Tetanus Toxoid

1996